Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipidome and Microbiome Profile in Rosacea
NCT03655197Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Nov 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of doxycycline in rosacea (3 arms), sponsored by University of California, Davis. Primary endpoints: Lipidome Change in Diversity, Microbiome Change in Diversity and 2 more. Started Nov 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03655197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655197.